Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy-Reference-Cited by-同舟云学术

Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy

Published:2020-11 Issue:11 Volume:38 Page:849.e11-849.e18
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Shiota Masaki,Endo Satoshi,Fujimoto Naohiro,Tsukahara Shigehiro,Ushijima Miho,Kashiwagi Eiji,Takeuchi Ario,Inokuchi Junichi,Uchiumi Takeshi,Eto Masatoshi

Funder

JSPS KAKENHI

Japanese Urological Association

Takeda Science Foundation

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference36 articles.

1. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer;Shiota;Int J Urol,2016

2. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy;Morote;J Urol,2007

3. Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?;Perachino;BJU Int,2010

4. Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer;Bertaglia;Clin Genitourin Cancer,2013

5. Nadir testosterone after long-term followup predicts prognosis in patients with prostate cancer treated with combined androgen blockade;Kamada;J Urol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Steroid 5-alpha Reductase Type-II Gene Polymorphisms (A49T and V89L) with Prostate Cancer Risk in African Population: A Systematic Review and Meta-analysis;Scientific African;2024-09

2. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer;Cancer Cell International;2023-10-19

3. Analysis of Genetic Biomarkers, Polymorphisms in ADME-Related Genes and their Impact on Pharmacotherapy for Prostate Cancer;2023-08-17

4. Influence of aldo–keto reductase 1C3 polymorphisms in early-onset female psoriasis patients;Scientific Reports;2023-02-25

5. Germline Mutations in Steroid Metabolizing Enzymes: A Focus on Steroid Transforming Aldo-Keto Reductases;International Journal of Molecular Sciences;2023-01-18